A Clinical Trial of Cidabenamine Plus Azacitidine to Prevent Post-Transplant Progression in High-Risk Peripheral T-Cell Lymphoma

Clinical trial NCT07389616 · RECRUITING

Trial details

NCT number: NCT07389616
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Peripheral T Cell Lymphoma

Start date: 2026-02-01
Primary completion: 2028-02-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.